{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:10:00Z","timestamp":1789175400556,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"DOI":"10.1007\/s12308-026-00730-5","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:46:32Z","timestamp":1789130792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Large B-cell lymphoma with IRF4 rearrangement: clinicopathologic heterogeneity across the age spectrum"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5843-4851","authenticated-orcid":false,"given":"Sehbal","family":"Arslankoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8905-0199","authenticated-orcid":false,"given":"Ece","family":"\u00d6zo\u011ful","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1918-4407","authenticated-orcid":false,"given":"Tezer","family":"Kutluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7542-9229","authenticated-orcid":false,"given":"Serkan","family":"Ak\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0076-8293","authenticated-orcid":false,"given":"Emine Arzu Sa\u011flam","family":"Ayhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2522-1606","authenticated-orcid":false,"given":"Ay\u015feg\u00fcl","family":"\u00dcner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"7","key":"730_CR1","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/ni1357","volume":"7","author":"U Klein","year":"2006","unstructured":"Klein U, Casola S, Cattoretti G, Shen Q, Lia M, Mo T et al (2006) Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 7(7):773\u201382","journal-title":"Nat Immunol"},{"issue":"2","key":"730_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.immuni.2006.07.009","volume":"25","author":"R Sciammas","year":"2006","unstructured":"Sciammas R, Shaffer AL, Schatz JH, Zhao H, Staudt LM, Singh H (2006) Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 25(2):225\u201336","journal-title":"Immunity"},{"issue":"10","key":"730_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.it.2008.07.006","volume":"29","author":"R Lu","year":"2008","unstructured":"Lu R (2008) Interferon regulatory factor 4 and 8 in B-cell development. Trends Immunol 29(10):487\u2013492","journal-title":"Trends Immunol"},{"issue":"7201","key":"730_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature07064","volume":"454","author":"AL Shaffer","year":"2008","unstructured":"Shaffer AL, Emre NC, Lamy L, Ngo VN, Wright G, Xiao W et al (2008) IRF4 addiction in multiple myeloma. Nature 454(7201):226\u2013231","journal-title":"Nature"},{"issue":"7","key":"730_CR5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","volume":"38","author":"J Morscio","year":"2014","unstructured":"Morscio J, Dierickx D, Nijs J, Verhoef G, Bittoun E, Vanoeteren X et al (2014) Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases. Am J Surg Pathol 38(7):875\u201386","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"730_CR6","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s10238-022-00968-0","volume":"23","author":"R Maffei","year":"2023","unstructured":"Maffei R, Fiorcari S, Atene CG, Martinelli S, Mesini N, Pilato F et al (2023) The dynamic functions of IRF4 in B cell malignancies. Clin Exp Med 23(4):1171\u20131180","journal-title":"Clin Exp Med"},{"key":"730_CR7","volume-title":"WHO classification of tumours: haematolymphoid tumours","author":"WHO Classification of Tumours Editorial Board","year":"2024","unstructured":"WHO Classification of Tumours Editorial Board (2024) WHO classification of tumours: haematolymphoid tumours, 5 ed. International Agency for Research on Cancer, Lyon, France","edition":"5 ed"},{"issue":"11","key":"730_CR8","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC et al (2022) The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140(11):1229\u201353","journal-title":"Blood"},{"issue":"1","key":"730_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","volume":"118","author":"I Salaverria","year":"2011","unstructured":"Salaverria I, Philipp C, Oschlies I, Kohler CW, Kreuz M, Szczepanowski M et al (2011) Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood 118(1):139\u2013147","journal-title":"Blood"},{"issue":"4","key":"730_CR10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1182\/blood.2019002699","volume":"135","author":"JE Ramis-Zaldivar","year":"2020","unstructured":"Ramis-Zaldivar JE, Gonzalez-Farre B, Balague O, Celis V, Nadeu F, Salmeron-Villalobos J et al (2020) Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. Blood 135(4):274\u2013286","journal-title":"Blood"},{"issue":"3","key":"730_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/pin.13067","volume":"71","author":"L Zhou","year":"2021","unstructured":"Zhou L, Gu B, Shen X, Binshen O, Dong L, Zhou J et al (2021) B cell lymphoma with IRF4 rearrangement: a clinicopathological study of 13 cases. Pathol Int 71(3):183\u2013190","journal-title":"Pathol Int"},{"issue":"7","key":"730_CR12","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/his.14885","volume":"82","author":"EAM Hesius","year":"2023","unstructured":"Hesius EAM, van Laar L, Oosterveld M, van Spriel AB, Scheijen B, Leeuwis JW et al (2023) Reclassification of diffuse large B cell lymphoma to large B cell lymphoma with IRF4 rearrangement in an adult population. Histopathology 82(7):1013\u201320","journal-title":"Histopathology"},{"issue":"1","key":"730_CR13","volume":"18","author":"R Horaguchi","year":"2026","unstructured":"Horaguchi R, Kikuchi S, Nabe Y, Kisamori S, Minemura T, Fujihira T et al (2026) Large B-cell Lymphoma With IRF4 Rearrangement in the Elderly. Cureus 18(1):e102294","journal-title":"Cureus"},{"issue":"3","key":"730_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00428-023-03689-1","volume":"484","author":"M Pizzi","year":"2024","unstructured":"Pizzi M, Bongiovanni L, Lorenzi L, Righi S, Scarmozzino F, Balzarini P et al (2024) Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes. Virchows Arch 484(3):521\u2013526","journal-title":"Virchows Arch"},{"key":"730_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.humpath.2022.10.011","volume":"131","author":"HE Berg","year":"2023","unstructured":"Berg HE, Peterson JF, Lee HE, McPhail ED (2023) Large B-cell lymphoma with IRF4 gene rearrangements: differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult patients. Hum Pathol 131:108\u2013115","journal-title":"Hum Pathol"},{"issue":"1","key":"730_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70295","volume":"10","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Li A, Li Y, Wang X, Dong L, Zhang L et al (2026) Biological heterogeneity in adult IRF4-rearranged large B-cell lymphoma: Stratification by age and anatomical site. HemaSphere 10(1):e70295","journal-title":"HemaSphere"},{"key":"730_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/his.70169","author":"S Na","year":"2026","unstructured":"Na S, Lee KR, Jeon YK, Kim H, Lee JO, Lee JY et al (2026) Clinicopathological spectrum of CD10, BCL6, MUM1 triple-positive diffuse large B-cell lymphoma and large B-cell lymphoma with IRF4 rearrangement. Histopathology. https:\/\/doi.org\/10.1111\/his.70169","journal-title":"Histopathology"},{"issue":"9","key":"730_CR18","doi-asserted-by":"publisher","first-page":"10684","DOI":"10.1002\/cam4.5828","volume":"12","author":"XN Jiang","year":"2023","unstructured":"Jiang XN, Yu F, Xue T, Xia QX, Bai QM, Yu BH et al (2023) IRF4 rearrangement may predict favorable prognosis in children and young adults with primary head and neck large B-cell lymphoma. Cancer Med 12(9):10684\u201310693","journal-title":"Cancer Med"},{"issue":"1","key":"730_CR19","volume":"17","author":"A Abdulrahim","year":"2025","unstructured":"Abdulrahim A, Sabri A, Teruya B, Li C, Cantu D (2025) Case series: large B-cell lymphoma with IRF4 rearrangement involving the lung and tonsil in two different patients. Cureus 17(1):e76758","journal-title":"Cureus"},{"issue":"5","key":"730_CR20","volume":"17","author":"H Cutshall","year":"2025","unstructured":"Cutshall H, Patel VM, Ferguson PE, Levy RA, Gokden M (2025) Large B-cell lymphoma with interferon regulatory factor 4 rearrangement presenting as a primary central nervous system lymphoma in the brain. Cureus 17(5):e83753","journal-title":"Cureus"},{"issue":"7","key":"730_CR21","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1182\/bloodadvances.2021006034","volume":"6","author":"L Frauenfeld","year":"2022","unstructured":"Frauenfeld L, Castrejon-de-Anta N, Ramis-Zaldivar JE, Streich S, Salmeron-Villalobos J, Otto F et al (2022) Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements. Blood Adv 6(7):2361\u201372","journal-title":"Blood Adv"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00730-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-026-00730-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00730-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:02:21Z","timestamp":1789174941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-026-00730-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["730"],"URL":"https:\/\/doi.org\/10.1007\/s12308-026-00730-5","relation":{},"ISSN":["1865-5785"],"issn-type":[{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"14 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research received no specific funding.","order":1,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Hacettepe University Health Sciences Research Ethics Committee (approval number: SBA 26\/340; decision number: 2026\/08\u201334; approval date: April 14, 2026).","order":3,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Owing to the retrospective design and anonymised data collection, the requirement for informed consent was waived.","order":4,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"54"}}